COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #40 of 231
5/18 Early treatment study
Ahmad et al., doi:10.1101/2020.05.18.20066902 (Preprint)
Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities
Source   PDF   Share   Tweet
54 patients in long term care facilities. 6% death with HCQ+AZ compared to 22% using a naive indirect comparison.

Ahmad et al., 5/18/2020, preprint, 5 authors.
Details of all 231 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit